site stats

Cytokinetics 10-k

Web如果您是机构,请点击下方了解我们为ria、对冲基金、合规官员等提供的服务。 WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Cytokinetics To Participate In The 22nd Annual Needham Virtual ...

WebAnalyst Cody Fincher found an unusual item yesterday in Cytokinetics’ (CYTK) 10-K. By David Trainer Contributor. Nov 17, 2015. Cashing In On Cytokinetics, Selling Puts On Wal-Mart. WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. ... 10-K Filing Date. list of 50 states and abbreviations printable https://ifixfonesrx.com

FDA Action Alert: Cytokinetics, Reata, Regeneron, Pfizer and GSK

WebMar 29, 2024 · Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments ... WebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ... WebApr 29, 2004 · How do I get a copy of Cytokinetics' financial statements, such as Form 10-Q, Form 10-K, Form 8-K or the Annual Report, when available? Our Form 10-Qs, Form 10-Ks, Form 8-Ks and other reports, when available, are listed on the SEC's web site, www.sec.gov , please search on "Cytokinetics" or visit the Investor Center's SEC links … list of 50 states and capitals free printable

Cytokinetics Reports Second Quarter 2024 Financial Results

Category:Cytokinetics LinkedIn

Tags:Cytokinetics 10-k

Cytokinetics 10-k

Cytokinetics, Inc. (CYTK) Stock Price & News - Google Finance

WebFeb 27, 2024 · On Feb. 28, the FDA is set to decide on Cytokinetics ’ omecamtiv mecarbil (OM), a novel, selective cardiac myosin activator being evaluated for heart failure with reduced ejection fraction. The regulatory agency accepted the New Drug Application for OM in February 2024 and initially set a target action date of Nov. 30, 2024. WebJul 30, 2014 · Company Provides Updates to Development Programs Focused to Muscle Biology SOUTH SAN FRANCISCO, CA, July 30, 2014 - Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development ...

Cytokinetics 10-k

Did you know?

WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential ...

WebFeb 27, 2024 · For Cytokinetics, an FDA rejection of its heart drug would help, not hinder. By Adam Feuerstein. Reprints. Molly Ferguson/STAT. C ytokinetics was founded 26 years ago but has not yet developed a ... WebAug 4, 2024 · SOUTH SAN FRANCISCO, Calif., Aug. 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the second …

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. Leadership Team. Grant Programs. Advocacy … WebMar 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised.

WebApr 8, 2024 · Cytokinetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes: Voting Procedures; Board Members; ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word …

WebApr 9, 2024 · Shares of CYTK stock opened at $36.42 on Friday. The stock has a fifty day moving average price of $39.79 and a 200 day moving average price of $42.22. The stock has a market cap of $3.48 billion ... list of 50 states in the usaWebMar 1, 2024 · Cytokinetics Inc (CYTK) 10-K Annual Report Wed Mar 01 2024 Earnings Press Release 10-K Annual Report 10-K YoY Changes Cytokinetics Inc CIK: 1061983 … list of 50 states word documentWebCYTK Cytokinetics Inc Annual Report (10-k) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL … list of 50 states textWebApr 10, 2024 · Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory setback for its NDA for omecamtiv mecarbil. 20h ago list of 50 states to printWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. list of 50 u.s. statesWebView the 10k annual report for CYTK stock. See latest earnings, revenues, margins, and growth rates. list of 50\u0027s moviesWebCytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the … list of 5200 games